Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Hepatocellular Carcinoma and Viral Hepatitis in New York City.

Moore MS, Ivanina E, Bornschlegel K, Qiao B, Schymura MJ, Laraque F.

Clin Infect Dis. 2016 Dec 15;63(12):1577-1583. Epub 2016 Sep 1.

PMID:
27585801
2.

Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011.

Pinchoff J, Tran OC, Chen L, Bornschlegel K, Drobnik A, Kersanske L, Fuld J.

Epidemiol Infect. 2016 Dec;144(16):3354-3364. doi: 10.1017/S0950268816001801. Epub 2016 Aug 11.

PMID:
27510414
3.

Barriers to Treatment Among New York City Residents with Chronic Hepatitis C Virus Infection, 2014.

King A, Bornschlegel K, Johnson N, Rude E, Laraque F.

Public Health Rep. 2016 May-Jun;131(3):430-7.

4.

Factors Associated With Hepatitis C Infection Among HIV-Infected Men Who Have Sex With Men With No Reported Injection Drug Use in New York City, 2000-2010.

Breskin A, Drobnik A, Pathela P, Chan C, Braunstein S, Bornschlegel K, Fuld J.

Sex Transm Dis. 2015 Jul;42(7):382-6. doi: 10.1097/OLQ.0000000000000293.

PMID:
26222751
5.

Hepatitis C surveillance among youth and young adults in New York City, 2009-2013.

Prussing C, Bornschlegel K, Balter S.

J Urban Health. 2015 Apr;92(2):387-99. doi: 10.1007/s11524-014-9920-5.

6.

Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010.

Bushnell G, Stennis NL, Drobnik AM, Proops DC, Ahuja SD, Bornschlegel K, Fuld J.

Epidemiol Infect. 2015 Jul;143(9):1972-81. doi: 10.1017/S0950268814002970. Epub 2014 Nov 12.

PMID:
25387450
7.

Duplicate hepatitis C antibody testing in New York City, 2006-2010.

Tsai V, Bornschlegel K, McGibbon E, Arpadi S.

Public Health Rep. 2014 Nov-Dec;129(6):491-5.

8.

HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics.

Prussing C, Chan C, Pinchoff J, Kersanske L, Bornschlegel K, Balter S, Drobnik A, Fuld J.

Epidemiol Infect. 2015 May;143(7):1408-16. doi: 10.1017/S0950268814002209. Epub 2014 Aug 29.

PMID:
25170631
9.

Deaths among people with hepatitis C in New York City, 2000-2011.

Pinchoff J, Drobnik A, Bornschlegel K, Braunstein S, Chan C, Varma JK, Fuld J.

Clin Infect Dis. 2014 Apr;58(8):1047-54. doi: 10.1093/cid/ciu075. Epub 2014 Feb 12.

PMID:
24523215
10.

Reassessing provider reporting in the age of electronic surveillance.

Stachel AG, Waechter H, Bornschlegel K, Reddy V, Hanson H, Wen T, Baumgartner J, Balter S.

J Public Health Manag Pract. 2014 Mar-Apr;20(2):240-5. doi: 10.1097/PHH.0b013e31829d8047.

PMID:
24458313
11.

Enhanced chronic hepatitis C surveillance in New York City, April 2009-January 2011.

Drezner K, Bornschlegel K, McGibbon E, Balter S.

Public Health Rep. 2013 Nov-Dec;128(6):510-8.

12.

Medication injection safety knowledge and practices among anesthesiologists: New York State, 2011.

Gounder P, Beers R, Bornschlegel K, Hinterland K, Balter S.

J Clin Anesth. 2013 Nov;25(7):521-8. doi: 10.1016/j.jclinane.2013.04.013. Epub 2013 Sep 2.

PMID:
24008193
13.

Half a diagnosis: gap in confirming infection among hepatitis C antibody-positive patients.

McGibbon E, Bornschlegel K, Balter S.

Am J Med. 2013 Aug;126(8):718-22. doi: 10.1016/j.amjmed.2013.01.031. Epub 2013 Jun 17.

PMID:
23786667
14.

Estimating the prevalence of hepatitis C infection in New York City using surveillance data.

Balter S, Stark JH, Kennedy J, Bornschlegel K, Konty K.

Epidemiol Infect. 2014 Feb;142(2):262-9. doi: 10.1017/S0950268813000952. Epub 2013 May 9.

15.

Hepatitis C transmission due to contamination of multidose medication vials: summary of an outbreak and a call to action.

Branch-Elliman W, Weiss D, Balter S, Bornschlegel K, Phillips M.

Am J Infect Control. 2013 Jan;41(1):92-4. doi: 10.1016/j.ajic.2012.01.022. Epub 2012 May 25.

PMID:
22632822
16.

Case-control study of hepatitis B and hepatitis C in older adults: Do healthcare exposures contribute to burden of new infections?

Perz JF, Grytdal S, Beck S, Fireteanu AM, Poissant T, Rizzo E, Bornschlegel K, Thomas A, Balter S, Miller J, Klevens RM, Finelli L.

Hepatology. 2013 Mar;57(3):917-24. doi: 10.1002/hep.25688. Epub 2013 Jan 7.

PMID:
22383058
17.

Characteristics, services, and infection control practices of New York City assisted living facilities, 2010.

Stachel AG, Bornschlegel K, Balter S.

J Am Geriatr Soc. 2012 Feb;60(2):284-9. doi: 10.1111/j.1532-5415.2011.03817.x. Epub 2012 Jan 30.

PMID:
22288553
18.

Estimating the prevalence of chronic hepatitis B virus infection--New York City, 2008.

France AM, Bornschlegel K, Lazaroff J, Kennedy J, Balter S.

J Urban Health. 2012 Apr;89(2):373-83. doi: 10.1007/s11524-011-9653-7.

19.

Unmet needs among people reported with hepatitis C, New York City.

Bornschlegel K, Crotty KJ, Sahl S, Balter S.

J Public Health Manag Pract. 2011 Jul-Aug;17(4):E9-17. doi: 10.1097/PHH.0b013e3182053f1b.

PMID:
21617400
20.

Prevalence of hepatitis C infection in New York City, 2004.

Bornschlegel K, Berger M, Garg RK, Punsalang A, McKinney CM, Gwynn RC, Thorpe LE.

J Urban Health. 2009 Nov;86(6):909-17. doi: 10.1007/s11524-009-9396-x.

21.

A recurring outbreak of Shigella sonnei among traditionally observant Jewish children in New York City: the risks of daycare and household transmission.

Garrett V, Bornschlegel K, Lange D, Reddy V, Kornstein L, Kornblum J, Agasan A, Hoekstra M, Layton M, Sobel J.

Epidemiol Infect. 2006 Dec;134(6):1231-6. Epub 2006 Apr 20.

22.

A large outbreak of hepatitis B virus infections associated with frequent injections at a physician's office.

Samandari T, Malakmadze N, Balter S, Perz JF, Khristova M, Swetnam L, Bornschlegel K, Phillips MS, Poshni IA, Nautiyal P, Nainan OV, Bell BP, Williams IT.

Infect Control Hosp Epidemiol. 2005 Sep;26(9):745-50.

PMID:
16209380
23.

Enhanced drop-in syndromic surveillance in New York City following September 11, 2001.

Das D, Weiss D, Mostashari F, Treadwell T, McQuiston J, Hutwagner L, Karpati A, Bornschlegel K, Seeman M, Turcios R, Terebuh P, Curtis R, Heffernan R, Balter S.

J Urban Health. 2003 Jun;80(2 Suppl 1):i76-88.

24.

Aging cohort of perinatally human immunodeficiency virus-infected children in New York City. New York City Pediatric Surveillance of Disease Consortium.

Abrams EJ, Weedon J, Bertolli J, Bornschlegel K, Cervia J, Mendez H, Lambert G, Singh T, Thomas P; New York City Pediatric Surveillance of Disease Consortium. Centers for Disease Control and Prevention.

Pediatr Infect Dis J. 2001 May;20(5):511-7.

PMID:
11368109
25.

Tuberculosis in human immunodeficiency virus-infected and human immunodeficiency virus-exposed children in New York City. The New York City Pediatric Spectrum of HIV Disease Consortium.

Thomas P, Bornschlegel K, Singh TP, Abrams EJ, Cervia J, Fikrig S, Lambert G, Mendez H, Kaye K, Bertolli J.

Pediatr Infect Dis J. 2000 Aug;19(8):700-6.

PMID:
10959736
26.

Short courses of zidovudine and perinatal transmission of HIV.

Thomas P, Bornschlegel K.

N Engl J Med. 1999 Apr 1;340(13):1041; author reply 1042-3. No abstract available.

PMID:
10189282
27.

Tissue-specific and developmental stage-specific DNA binding by a mammalian SWI/SNF complex associated with human fetal-to-adult globin gene switching.

O'Neill D, Yang J, Erdjument-Bromage H, Bornschlegel K, Tempst P, Bank A.

Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):349-54.

28.

The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group.

Thea DM, Steketee RW, Pliner V, Bornschlegel K, Brown T, Orloff S, Matheson PB, Abrams EJ, Bamji M, Lambert G, Schoenbaum EA, Thomas PA, Heagarty M, Kalish ML.

AIDS. 1997 Mar 15;11(4):437-44.

PMID:
9084790
29.

Expression of a cosmid containing the LCR, (A)gamma, delta, and beta globin genes in mouse erythroleukemia cells.

Flamm M, Bornschlegel K, Wu S, O'Neill D, Bank A.

Am J Hematol. 1996 Nov;53(3):181-7.

30.

A DNA-binding factor in adult hematopoietic cells interacts with a pyrimidine-rich domain upstream from the human delta-globin gene.

O'Neill D, Bornschlegel K, Flamm M, Castle M, Bank A.

Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8953-7.

31.

A novel strategy for the generation of T cell lines lacking expression of endogenous alpha- and/or beta-chain T cell receptor genes.

Glaichenhaus N, Davis C, Bornschlegel K, Allison JP, Shastri N.

J Immunol. 1991 Apr 1;146(7):2095-101.

PMID:
1826016

Supplemental Content

Loading ...
Support Center